Illumina Company Profile (NASDAQ:ILMN)

About Illumina (NASDAQ:ILMN)

Illumina logoIllumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:ILMN
  • CUSIP: 45232710
  • Web: www.illumina.com
Capitalization:
  • Market Cap: $25.2215 billion
  • Outstanding Shares: 146,000,000
Average Prices:
  • 50 Day Moving Avg: $175.17
  • 200 Day Moving Avg: $171.09
  • 52 Week Range: $119.37 - $189.48
P/E:
  • Trailing P/E Ratio: 35.21
  • Foreward P/E Ratio: 39.81
  • P/E Growth: 3.37
Sales & Book Value:
  • Annual Revenue: $2.42 billion
  • Price / Sales: 10.50
  • Book Value: $17.47 per share
  • Price / Book: 9.96
Profitability:
  • EBIDTA: $678.78 million
  • Net Margins: 30.75%
  • Return on Equity: 21.21%
  • Return on Assets: 11.52%
Debt:
  • Debt-to-Equity Ratio: 0.41%
  • Current Ratio: 3.49%
  • Quick Ratio: 3.08%
Misc:
  • Average Volume: 980,494 shs.
  • Beta: 0.84
  • Short Ratio: 4.39
 
Frequently Asked Questions for Illumina (NASDAQ:ILMN)

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina, Inc. (NASDAQ:ILMN) issued its earnings results on Tuesday, November, 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.87 by $0.10. The business earned $607 million during the quarter, compared to the consensus estimate of $628.06 million. Illumina had a net margin of 30.75% and a return on equity of 21.21%. Illumina's revenue was up 10.4% on a year-over-year basis. During the same period last year, the business posted $0.80 EPS. View Illumina's Earnings History.

Where is Illumina's stock going? Where will Illumina's stock price be in 2017?

20 analysts have issued 12-month price targets for Illumina's stock. Their forecasts range from $116.00 to $200.00. On average, they expect Illumina's stock price to reach $162.42 in the next year. View Analyst Ratings for Illumina.

Who are some of Illumina's key competitors?

Who are Illumina's key executives?

Illumina's management team includes the folowing people:

  • Jay T. Flatley, Executive Chairman of the Board
  • Francis A. deSouza, President, Chief Executive Officer, Director
  • Sam Samad, Chief Financial Officer, Senior Vice President
  • Marc A. Stapley, Executive Vice President, Chief Administrative Officer
  • Garret Hampton Ph.D., Executive Vice President - Clinical Genomics
  • Omead Ostadan, Executive Vice President - Operations, Products and Strategy
  • Mostafa Ronaghi Ph.D., Chief Technology Officer, Senior Vice President
  • Charles E. Dadswell, Senior Vice President, General Counsel, Secretary
  • Mark Van Oene, Senior Vice President, Chief Commercial Officer
  • Arthur Blaine Bowman, Lead Independent Director

Who owns Illumina stock?

Illumina's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Douglas Lane & Associates LLC (0.33%), Chevy Chase Trust Holdings Inc. (0.26%), Rockefeller Financial Services Inc. (0.23%), State Treasurer State of Michigan (0.18%), National Pension Service (0.09%) and PGGM Investments (0.08%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Nicholas Naclerio, Omead Ostadan, Paul L Bianchi, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Who sold Illumina stock? Who is selling Illumina stock?

Illumina's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Bank of Montreal Can, Rockefeller Financial Services Inc., Creative Planning, Gateway Investment Advisers LLC, Exxonmobil Investment Management Inc. TX, Douglas Lane & Associates LLC and Greenleaf Trust. Company insiders that have sold Illumina stock in the last year include A Blaine Bowman, Charles Dadswell, Daniel Bradbury, Frances Arnold, Jay T Flatley, Marc Stapley, Michel Bouchard, Omead Ostadan, Robert S Epstein and Roy A Whitfield. View Insider Buying and Selling for Illumina.

Who bought Illumina stock? Who is buying Illumina stock?

Illumina's stock was bought by a variety of institutional investors in the last quarter, including Chevy Chase Trust Holdings Inc., Mn Services Vermogensbeheer B.V., Mitsubishi UFJ Asset Management UK Ltd., Aperio Group LLC, National Pension Service, Private Asset Management Inc., State of Alaska Department of Revenue and CrestPoint Capital Management LLC. View Insider Buying and Selling for Illumina.

How do I buy Illumina stock?

Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of Illumina stock can currently be purchased for approximately $173.99.


MarketBeat Community Rating for Illumina (NASDAQ ILMN)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  629 (Vote Outperform)
Underperform Votes:  608 (Vote Underperform)
Total Votes:  1,237
MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Illumina (NASDAQ:ILMN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Sell Ratings, 9 Hold Ratings, 8 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $162.42 (6.65% downside)

Analysts' Ratings History for Illumina (NASDAQ:ILMN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/19/2017Barclays PLCReiterated RatingHold$150.00LowView Rating Details
7/10/2017Morgan StanleyReiterated RatingUnderweight$115.00 -> $122.00HighView Rating Details
4/29/2017Deutsche Bank AGReiterated RatingHold$165.00 -> $175.00LowView Rating Details
4/26/2017Cowen and CompanyReiterated RatingOutperform$200.00HighView Rating Details
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral -> Neutral$155.00 -> $170.00HighView Rating Details
4/14/2017Piper Jaffray CompaniesReiterated RatingOverweight$170.00 -> $187.00N/AView Rating Details
4/11/2017Bank of America CorporationBoost Price TargetBuy$175.00 -> $195.00LowView Rating Details
4/5/2017Leerink SwannReiterated RatingBuyMediumView Rating Details
3/19/2017BTIG ResearchReiterated RatingHoldMediumView Rating Details
2/27/2017Evercore ISIUpgradeHold -> Buy$190.00N/AView Rating Details
2/21/2017Canaccord GenuityReiterated RatingHold$150.00N/AView Rating Details
1/12/2017Robert W. BairdReiterated RatingNeutral$147.00 -> $153.00N/AView Rating Details
1/6/2017Janney Montgomery ScottReiterated RatingNeutral -> Sell$125.00N/AView Rating Details
1/6/2017CL KingUpgradeNeutral -> BuyN/AView Rating Details
11/2/2016First AnalysisDowngradeEqual Weight -> Underweight$130.00 -> $116.00N/AView Rating Details
10/14/2016ArgusReiterated RatingBuy$205.00 -> $170.00N/AView Rating Details
10/12/2016Wells Fargo & CompanyReiterated RatingMarket Perform$150.00 -> $137.50N/AView Rating Details
10/11/2016Citigroup Inc.DowngradeBuy -> Neutral$190.00 -> $140.00N/AView Rating Details
7/27/2016J P Morgan Chase & CoBoost Price TargetOverweight$185.00 -> $200.00N/AView Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$138.00 -> $148.00N/AView Rating Details
5/4/2016Stifel NicolausReiterated RatingBuy$215.00 -> $160.00N/AView Rating Details
5/3/2016NomuraLower Price TargetBuy$210.00 -> $180.00N/AView Rating Details
4/22/2016Avondale PartnersReiterated RatingMarket Perform$175.00 -> $160.00N/AView Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Lower Price Target$141.00N/AView Rating Details
10/21/2015WedbushBoost Price TargetOutperform$150.00 -> $160.00N/AView Rating Details
10/8/2015William BlairReiterated RatingBuyN/AView Rating Details
(Data available from 7/25/2015 forward)

Earnings

Earnings History for Illumina (NASDAQ:ILMN)
Earnings by Quarter for Illumina (NASDAQ:ILMN)
Earnings History by Quarter for Illumina (NASDAQ ILMN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2017Q1 2017$0.64$0.64$590.51 million$598.00 millionViewN/AView Earnings Details
1/31/2017Q416$0.82$0.85$612.50 million$619.00 millionViewListenView Earnings Details
11/1/2016Q316$0.87$0.97$628.06 million$607.00 millionViewListenView Earnings Details
7/26/2016Q2$0.73$0.86$31.91 million$600.00 millionViewListenView Earnings Details
5/3/2016Q1$0.74$0.71$596.33 million$572.00 millionViewListenView Earnings Details
2/2/2016Q415$0.82$0.81$576.39 million$591.50 millionViewListenView Earnings Details
10/20/2015Q315$0.79$0.80$568.60 million$550.00 millionViewListenView Earnings Details
7/21/2015Q215$0.77$0.80$541.05 million$539.00 millionViewListenView Earnings Details
4/21/2015Q115$0.72$0.91$524.35 million$539.00 millionViewListenView Earnings Details
1/27/2015Q414$0.78$0.87$503.83 million$512.00 millionViewListenView Earnings Details
10/20/2014Q314$0.56$0.77$451.20 million$481.00 millionViewListenView Earnings Details
7/23/2014Q214$0.51$0.57$426.50 million$448.00 millionViewListenView Earnings Details
4/22/2014Q114$0.44$0.53$391.50 million$421.00 millionViewListenView Earnings Details
1/28/2014Q413$0.44$0.45$382.06 million$387.00 millionViewListenView Earnings Details
10/21/2013Q313$0.40$0.45$343.42 million$357.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.40$0.43$331.77 million$346.09 millionViewListenView Earnings Details
4/22/2013Q1 2013$0.39$0.46$310.64 million$330.96 millionViewListenView Earnings Details
1/28/2013Q4 2012$0.41$0.42$303.13 million$309.30 millionViewListenView Earnings Details
10/23/2012$0.39$0.41ViewN/AView Earnings Details
7/24/2012$0.36$0.40ViewN/AView Earnings Details
4/23/2012$0.32$0.36ViewN/AView Earnings Details
2/7/2012$0.30$0.35ViewN/AView Earnings Details
10/25/2011$0.23$0.22ViewN/AView Earnings Details
4/26/2011$0.31$0.35ViewN/AView Earnings Details
2/8/2011$0.29$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Illumina (NASDAQ:ILMN)
2017 EPS Consensus Estimate: $3.63
2018 EPS Consensus Estimate: $4.36
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.63$0.82$0.69
Q2 20173$0.65$0.85$0.72
Q3 20173$0.95$1.14$1.06
Q4 20173$1.04$1.27$1.16
Q1 20183$0.76$1.04$0.94
Q2 20182$1.05$1.07$1.06
Q3 20182$1.12$1.17$1.15
Q4 20182$1.17$1.26$1.22
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Illumina (NASDAQ:ILMN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Illumina (NASDAQ:ILMN)
Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 93.75%
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)
Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/18/2017Jay T FlatleyDirectorSell15,000$170.77$2,561,550.00View SEC Filing  
7/14/2017Marc StapleyEVPSell2,000$173.56$347,120.00View SEC Filing  
7/7/2017Omead OstadanEVPSell1,672$172.73$288,804.56View SEC Filing  
7/5/2017Jay T FlatleyDirectorSell15,000$172.92$2,593,800.00View SEC Filing  
7/3/2017Charles DadswellSVPSell145$174.24$25,264.80View SEC Filing  
6/23/2017Michel BouchardInsiderSell246$185.00$45,510.00View SEC Filing  
6/22/2017Jay T FlatleyDirectorSell20,000$178.21$3,564,200.00View SEC Filing  
6/12/2017Marc StapleyEVPSell2,000$170.85$341,700.00View SEC Filing  
6/8/2017Michel BouchardInsiderSell246$178.91$44,011.86View SEC Filing  
6/6/2017Jay T FlatleyDirectorSell20,000$180.24$3,604,800.00View SEC Filing  
6/5/2017Charles DadswellSVPSell145$184.75$26,788.75View SEC Filing  
6/1/2017Jay T FlatleyDirectorSell3,320$180.55$599,426.00View SEC Filing  
5/25/2017Frances ArnoldDirectorSell825$174.77$144,185.25View SEC Filing  
5/23/2017Jay T FlatleyDirectorSell15,000$175.53$2,632,950.00View SEC Filing  
5/10/2017A Blaine BowmanDirectorSell2,300$181.61$417,703.00View SEC Filing  
5/9/2017Jay T FlatleyDirectorSell20,000$184.14$3,682,800.00View SEC Filing  
5/9/2017Michel BouchardInsiderSell5,740$184.68$1,060,063.20View SEC Filing  
5/3/2017Charles DadswellSVPSell1,609$187.07$300,995.63View SEC Filing  
4/12/2017A Blaine BowmanDirectorSell3,000$172.72$518,160.00View SEC Filing  
4/7/2017Daniel BradburyDirectorSell600$172.79$103,674.00View SEC Filing  
3/24/2017Omead OstadanEVPSell1,672$170.00$284,240.00View SEC Filing  
3/21/2017Daniel BradburyDirectorSell600$163.56$98,136.00View SEC Filing  
2/17/2017Daniel BradburyDirectorSell600$162.80$97,680.00View SEC Filing  
2/13/2017Omead OstadanEVPSell2,173$163.10$354,416.30View SEC Filing  
2/8/2017A Blaine BowmanDirectorSell3,000$162.74$488,220.00View SEC Filing  
2/6/2017Charles DadswellSVPSell572$161.26$92,240.72View SEC Filing  
1/30/2017Omead OstadanEVPSell259$160.90$41,673.10View SEC Filing  
1/19/2017Omead OstadanEVPSell2,378$160.06$380,622.68View SEC Filing  
1/11/2017A Blaine BowmanDirectorSell3,000$162.89$488,670.00View SEC Filing  
1/10/2017Charles DadswellSVPSell116$161.60$18,745.60View SEC Filing  
1/4/2017Daniel BradburyDirectorSell600$135.01$81,006.00View SEC Filing  
12/15/2016Omead OstadanEVPSell2,000$126.16$252,320.00View SEC Filing  
12/12/2016Daniel BradburyDirectorSell600$123.42$74,052.00View SEC Filing  
12/8/2016Omead OstadanEVPSell3,000$121.63$364,890.00View SEC Filing  
12/1/2016Omead OstadanEVPSell3,000$133.30$399,900.00View SEC Filing  
11/14/2016Daniel BradburyDirectorSell600$136.34$81,804.00View SEC Filing  
10/7/2016Daniel BradburyDirectorSell600$184.36$110,616.00View SEC Filing  
10/4/2016Charles DadswellSVPSell116$182.38$21,156.08View SEC Filing  
9/20/2016Robert S EpsteinDirectorSell300$174.29$52,287.00View SEC Filing  
9/15/2016Marc StapleyEVPSell1,270$172.87$219,544.90View SEC Filing  
9/14/2016Daniel BradburyDirectorSell600$171.25$102,750.00View SEC Filing  
8/23/2016Jay T FlatleyDirectorSell20,000$172.99$3,459,800.00View SEC Filing  
8/22/2016Robert S EpsteinDirectorSell300$170.27$51,081.00View SEC Filing  
8/17/2016Daniel BradburyDirectorSell600$168.42$101,052.00View SEC Filing  
8/15/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
8/12/2016Roy A WhitfieldDirectorSell4,000$167.22$668,880.00View SEC Filing  
8/9/2016Jay T FlatleyDirectorSell10,000$165.97$1,659,700.00View SEC Filing  
8/1/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
7/27/2016Charles DadswellSVPSell8,632$155.00$1,337,960.00View SEC Filing  
7/26/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/20/2016Robert S EpsteinDirectorSell1,200$150.00$180,000.00View SEC Filing  
7/18/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/14/2016A Blaine BowmanDirectorSell5,000$147.14$735,700.00View SEC Filing  
7/11/2016Christian O HenryEVPSell716$141.89$101,593.24View SEC Filing  
6/16/2016A Blaine BowmanDirectorSell5,000$135.08$675,400.00View SEC Filing  
6/15/2016Christian O HenryEVPSell2,141$137.90$295,243.90View SEC Filing  
6/13/2016Roy A WhitfieldDirectorSell3,800$140.44$533,672.00View SEC Filing  
6/1/2016Karin EasthamDirectorSell5,000$145.35$726,750.00View SEC Filing  
5/25/2016Christian O HenryEVPSell2,141$144.73$309,866.93View SEC Filing  
5/17/2016Christian O HenryEVPSell2,141$140.84$301,538.44View SEC Filing  
5/12/2016A Blaine BowmanDirectorSell5,000$137.11$685,550.00View SEC Filing  
4/27/2016Christian O HenryEVPSell2,141$138.46$296,442.86View SEC Filing  
4/18/2016Christian O HenryEVPSell2,141$176.01$376,837.41View SEC Filing  
4/18/2016Paul L BianchiVPSell1,884$175.00$329,700.00View SEC Filing  
4/14/2016A Blaine BowmanDirectorSell5,000$172.94$864,700.00View SEC Filing  
4/13/2016Christian O HenryEVPSell12,500$175.00$2,187,500.00View SEC Filing  
4/13/2016Paul L BianchiVPSell6,681$175.00$1,169,175.00View SEC Filing  
4/12/2016Jay T FlatleyCEOSell20,000$170.05$3,401,000.00View SEC Filing  
4/12/2016Roy A WhitfieldDirectorSell4,000$170.00$680,000.00View SEC Filing  
4/7/2016David R WaltDirectorSell4,000$168.90$675,600.00View SEC Filing  
4/5/2016Christian O HenryEVPSell2,141$166.07$355,555.87View SEC Filing  
4/4/2016Charles DadswellSVPSell8,382$167.81$1,406,583.42View SEC Filing  
3/23/2016Christian O HenryEVPSell2,141$155.05$331,962.05View SEC Filing  
3/22/2016Jay T FlatleyCEOSell10,000$154.18$1,541,800.00View SEC Filing  
3/21/2016Daniel BradburyDirectorSell1,200$155.63$186,756.00View SEC Filing  
3/21/2016Nicholas NaclerioSVPSell4,520$154.25$697,210.00View SEC Filing  
3/17/2016A Blaine BowmanDirectorSell5,000$145.24$726,200.00View SEC Filing  
3/15/2016David R WaltDirectorSell4,000$149.99$599,960.00View SEC Filing  
3/14/2016Christian O HenryEVPSell5,892$155.91$918,621.72View SEC Filing  
3/8/2016Charles DadswellSVPSell8,382$155.63$1,304,490.66View SEC Filing  
3/8/2016Jay T FlatleyCEOSell10,000$154.49$1,544,900.00View SEC Filing  
3/8/2016Omead OstadanEVPSell4,516$156.09$704,902.44View SEC Filing  
3/7/2016Charles DadswellSVPSell116$155.00$17,980.00View SEC Filing  
2/23/2016Jay T FlatleyCEOSell10,000$152.49$1,524,900.00View SEC Filing  
2/17/2016Daniel BradburyDirectorSell1,700$154.74$263,058.00View SEC Filing  
2/12/2016Roy A. WhitfieldDirectorSell3,750$140.30$526,125.00View SEC Filing  
2/1/2016Omead OstadanEVPSell1,108$156.73$173,656.84View SEC Filing  
1/26/2016Jay T. FlatleyCEOSell20,000$171.70$3,434,000.00View SEC Filing  
1/13/2016Jay T. FlatleyCEOSell20,000$168.81$3,376,200.00View SEC Filing  
1/4/2016Daniel BradburyDirectorSell1,700$182.80$310,760.00View SEC Filing  
12/28/2015Charles DadswellSVPSell168$188.63$31,689.84View SEC Filing  
12/22/2015Jay T. FlatleyCEOSell25,000$185.38$4,634,500.00View SEC Filing  
12/14/2015Roy A. WhitfieldDirectorSell3,750$175.07$656,512.50View SEC Filing  
12/11/2015Omead OstadanEVPSell260$179.90$46,774.00View SEC Filing  
12/11/2015Paul L BianchiVPSell197$179.90$35,440.30View SEC Filing  
12/10/2015Daniel BradburyDirectorSell1,700$182.37$310,029.00View SEC Filing  
12/8/2015Jay T. FlatleyCEOSell25,000$177.11$4,427,750.00View SEC Filing  
11/27/2015Robert S EpsteinDirectorSell1,000$185.56$185,560.00View SEC Filing  
11/25/2015Jay T. FlatleyCEOSell5,000$180.00$900,000.00View SEC Filing  
11/24/2015Jay T. FlatleyCEOSell20,000$173.27$3,465,400.00View SEC Filing  
11/16/2015Jay T. FlatleyCEOSell10,000$170.00$1,700,000.00View SEC Filing  
11/10/2015Daniel BradburyDirectorSell1,700$154.03$261,851.00View SEC Filing  
11/10/2015Jay T. FlatleyCEOSell10,000$154.58$1,545,800.00View SEC Filing  
11/3/2015Charles DadswellSVPSell158$150.00$23,700.00View SEC Filing  
10/15/2015Jay T. FlatleyCEOSell10,000$150.00$1,500,000.00View SEC Filing  
10/7/2015Daniel BradburyDirectorSell1,700$145.81$247,877.00View SEC Filing  
9/29/2015David R WaltDirectorSell2,000$171.65$343,300.00View SEC Filing  
9/22/2015Jay T. FlatleyCEOSell25,000$192.79$4,819,750.00View SEC Filing  
9/15/2015David R WaltDirectorSell2,000$206.45$412,900.00View SEC Filing  
9/14/2015Daniel BradburyDirectorSell1,700$203.89$346,613.00View SEC Filing  
9/9/2015Paul L. BianchiVPSell1,245$199.32$248,153.40View SEC Filing  
9/8/2015Jay T. FlatleyCEOSell25,000$194.87$4,871,750.00View SEC Filing  
9/8/2015Karin EasthamDirectorSell4,300$195.76$841,768.00View SEC Filing  
9/4/2015Roy A. WhitfieldDirectorSell4,500$192.63$866,835.00View SEC Filing  
9/1/2015David R WaltDirectorSell2,000$195.08$390,160.00View SEC Filing  
8/27/2015Jay T. FlatleyCEOSell25,000$200.16$5,004,000.00View SEC Filing  
8/18/2015David R WaltDirectorSell2,000$206.89$413,780.00View SEC Filing  
8/17/2015Daniel BradburyDirectorSell1,700$208.14$353,838.00View SEC Filing  
8/13/2015Jay T FlatleyCEOSell25,000$207.85$5,196,250.00View SEC Filing  
8/5/2015Roy A. WhitfieldDirectorSell4,500$215.22$968,490.00View SEC Filing  
7/24/2015A Blaine BowmanDirectorSell3,000$221.47$664,410.00View SEC Filing  
7/23/2015Jay T FlatleyCEOSell25,000$214.87$5,371,750.00View SEC Filing  
7/21/2015David R WaltDirectorSell12,000$235.24$2,822,880.00View SEC Filing  
7/17/2015Mostafa RonaghiSVPSell1,200$235.00$282,000.00View SEC Filing  
7/16/2015Christian O HenrySVPSell5,390$229.61$1,237,597.90View SEC Filing  
7/15/2015Mostafa RonaghiSVPSell3,000$227.19$681,570.00View SEC Filing  
7/14/2015David R WaltDirectorSell10,000$227.39$2,273,900.00View SEC Filing  
7/13/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
7/13/2015Michel BouchardCAOSell1,400$222.75$311,850.00View SEC Filing  
7/10/2015Omead OstadanSVPSell1,110$219.81$243,989.10View SEC Filing  
7/10/2015Robert S EpsteinDirectorSell2,000$219.81$439,620.00View SEC Filing  
7/9/2015Jay T FlatleyCEOSell25,000$218.10$5,452,500.00View SEC Filing  
7/7/2015David R WaltDirectorSell10,000$220.22$2,202,200.00View SEC Filing  
7/6/2015Daniel BradburyDirectorSell1,700$219.70$373,490.00View SEC Filing  
6/30/2015David R WaltDirectorSell10,000$217.64$2,176,400.00View SEC Filing  
6/25/2015Jay T FlatleyCEOSell25,000$220.34$5,508,500.00View SEC Filing  
6/24/2015A Blaine BowmanDirectorSell3,000$221.43$664,290.00View SEC Filing  
6/24/2015Christian O HenrySVPSell5,084$221.07$1,123,919.88View SEC Filing  
6/23/2015David R WaltDirectorSell12,000$220.11$2,641,320.00View SEC Filing  
6/17/2015Christian O HenrySVPSell3,751$215.71$809,128.21View SEC Filing  
6/16/2015David R WaltDirectorSell10,000$215.14$2,151,400.00View SEC Filing  
6/15/2015Nicholas NaclerioSVPSell6,590$214.33$1,412,434.70View SEC Filing  
6/15/2015Paul L BianchiVPSell3,408$215.83$735,548.64View SEC Filing  
6/12/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
6/12/2015Michel BouchardCAOSell1,400$216.11$302,554.00View SEC Filing  
6/11/2015Jay T FlatleyCEOSell25,000$216.41$5,410,250.00View SEC Filing  
6/10/2015Christian O HenrySVPSell10,000$214.94$2,149,400.00View SEC Filing  
6/10/2015Robert S EpsteinDirectorSell2,000$214.24$428,480.00View SEC Filing  
6/5/2015Roy A WhitfieldDirectorSell4,500$207.49$933,705.00View SEC Filing  
6/2/2015David R WaltDirectorSell10,000$204.42$2,044,200.00View SEC Filing  
6/1/2015Karin EasthamDirectorSell5,000$205.24$1,026,200.00View SEC Filing  
5/29/2015Daniel BradburyDirectorSell1,700$206.62$351,254.00View SEC Filing  
5/28/2015Jay T FlatleyCEOSell25,000$208.78$5,219,500.00View SEC Filing  
5/22/2015A Blaine BowmanDirectorSell3,000$204.58$613,740.00View SEC Filing  
5/19/2015David R WaltDirectorSell10,000$202.00$2,020,000.00View SEC Filing  
5/14/2015Christian O HenrySVPSell3,751$198.52$744,648.52View SEC Filing  
5/14/2015Jay T FlatleyCEOSell25,000$197.76$4,944,000.00View SEC Filing  
5/13/2015Paul L BianchiVPSell3,356$197.14$661,601.84View SEC Filing  
5/11/2015Robert S EpsteinDirectorSell2,000$196.49$392,980.00View SEC Filing  
4/28/2015David R WaltDirectorSell7,000$183.88$1,287,160.00View SEC Filing  
4/24/2015A Blaine BowmanDirectorSell3,000$190.73$572,190.00View SEC Filing  
4/23/2015Jay T FlatleyCEOSell25,000$189.57$4,739,250.00View SEC Filing  
4/21/2015David R WaltDirectorSell10,000$197.95$1,979,500.00View SEC Filing  
4/15/2015Christian O HenrySVPSell3,751$189.02$709,014.02View SEC Filing  
4/14/2015David R WaltDirectorSell7,000$188.23$1,317,610.00View SEC Filing  
4/13/2015Marc StapleyCFOSell3,000$190.12$570,360.00View SEC Filing  
4/13/2015Michel BouchardCAOSell1,400$188.61$264,054.00View SEC Filing  
4/13/2015Paul L BianchiVPSell3,390$187.22$634,675.80View SEC Filing  
4/10/2015Robert S EpsteinDirectorSell2,000$186.99$373,980.00View SEC Filing  
4/9/2015Jay T FlatleyCEOSell25,000$184.55$4,613,750.00View SEC Filing  
4/8/2015Daniel BradburyDirectorSell1,700$185.32$315,044.00View SEC Filing  
4/7/2015David R WaltDirectorSell5,000$184.28$921,400.00View SEC Filing  
4/6/2015Roy A WhitfieldDirectorSell4,600$181.32$834,072.00View SEC Filing  
3/26/2015Jay T FlatleyCEOSell25,000$181.34$4,533,500.00View SEC Filing  
3/24/2015David R WaltDirectorSell5,000$192.16$960,800.00View SEC Filing  
3/17/2015A Blaine BowmanDirectorSell3,000$192.30$576,900.00View SEC Filing  
3/16/2015Gerald MoellerDirectorSell2,700$193.36$522,072.00View SEC Filing  
3/16/2015Nicholas NaclerioSVPSell6,590$193.94$1,278,064.60View SEC Filing  
3/13/2015Paul L BianchiVPSell3,390$186.67$632,811.30View SEC Filing  
3/12/2015Marc StapleyCFOSell3,314$189.01$626,379.14View SEC Filing  
3/10/2015Richard KlausnerSVPSell1,186$191.75$227,415.50View SEC Filing  
3/10/2015Robert S EpsteinDirectorSell3,000$191.75$575,250.00View SEC Filing  
2/26/2015Jay T FlatleyCEOSell25,000$195.73$4,893,250.00View SEC Filing  
2/12/2015Jay T FlatleyCEOSell25,000$194.64$4,866,000.00View SEC Filing  
2/3/2015David R WaltDirectorSell7,000$190.89$1,336,230.00View SEC Filing  
2/2/2015Karin EasthamDirectorSell10,000$192.77$1,927,700.00View SEC Filing  
2/2/2015Nicholas NaclerioSVPSell15,250$194.37$2,964,142.50View SEC Filing  
1/27/2015Charles DadswellSVPSell224$198.90$44,553.60View SEC Filing  
1/27/2015David R WaltDirectorSell4,000$201.76$807,040.00View SEC Filing  
1/22/2015Jay T FlatleyCEOSell25,000$188.48$4,712,000.00View SEC Filing  
1/20/2015William H RastetterDirectorSell16,000$188.99$3,023,840.00View SEC Filing  
1/15/2015Marc StapleyCFOSell1,422$181.62$258,263.64View SEC Filing  
1/8/2015Jay T FlatleyCEOSell25,000$197.62$4,940,500.00View SEC Filing  
1/6/2015David R WaltDirectorSell6,000$188.55$1,131,300.00View SEC Filing  
1/2/2015Karin EasthamDirectorSell10,000$185.63$1,856,300.00View SEC Filing  
12/30/2014David R WaltDirectorSell5,000$186.95$934,750.00View SEC Filing  
12/29/2014Gerald MoellerDirectorSell8,000$187.05$1,496,400.00View SEC Filing  
12/26/2014Jay T FlatleyCEOSell25,000$186.71$4,667,750.00View SEC Filing  
12/23/2014David R WaltDirectorSell7,000$184.55$1,291,850.00View SEC Filing  
12/16/2014David R WaltDirectorSell5,000$178.35$891,750.00View SEC Filing  
12/15/2014Marc StapleyCFOSell1,422$181.09$257,509.98View SEC Filing  
12/11/2014Jay T FlatleyCEOSell25,000$185.79$4,644,750.00View SEC Filing  
12/9/2014David R WaltDirectorSell7,000$186.75$1,307,250.00View SEC Filing  
12/8/2014Daniel BradburyDirectorSell1,600$190.14$304,224.00View SEC Filing  
12/4/2014Karin EasthamDirectorSell10,000$191.87$1,918,700.00View SEC Filing  
12/1/2014Mostafa RonaghiSVPSell10,000$188.46$1,884,600.00View SEC Filing  
11/26/2014Paul L BianchiSVPSell1,626$189.20$307,639.20View SEC Filing  
11/17/2014Roy A WhitfieldDirectorSell4,000$178.26$713,040.00View SEC Filing  
11/14/2014Marc StapleyCFOSell1,422$181.13$257,566.86View SEC Filing  
11/13/2014Daniel BradburyDirectorSell2,100$186.88$392,448.00View SEC Filing  
11/13/2014Jay T FlatleyCEOSell25,000$189.32$4,733,000.00View SEC Filing  
11/3/2014Michel BouchardCAOSell631$195.68$123,474.08View SEC Filing  
11/3/2014Mostafa RonaghiSVPSell10,000$195.66$1,956,600.00View SEC Filing  
10/30/2014Daniel BradburyDirectorSell2,100$191.83$402,843.00View SEC Filing  
10/23/2014Jay T FlatleyCEOSell25,000$189.54$4,738,500.00View SEC Filing  
10/13/2014Daniel BradburyDirectorSell2,100$152.03$319,263.00View SEC Filing  
10/9/2014Jay T FlatleyCEOSell25,000$163.49$4,087,250.00View SEC Filing  
10/7/2014A Blaine BowmanDirectorSell4,456$159.51$710,776.56View SEC Filing  
10/1/2014Daniel BradburyDirectorSell2,100$158.88$333,648.00View SEC Filing  
10/1/2014Mostafa RonaghiSVPSell10,000$159.81$1,598,100.00View SEC Filing  
9/30/2014A Blaine BowmanDirectorSell5,000$164.02$820,100.00View SEC Filing  
9/29/2014Gerald MoellerDirectorSell5,000$164.89$824,450.00View SEC Filing  
9/25/2014Jay T FlatleyCEOSell25,000$164.43$4,110,750.00View SEC Filing  
9/24/2014Christian O HenrySVPSell20,000$167.28$3,345,600.00View SEC Filing  
9/23/2014A Blaine BowmanDirectorSell5,000$168.50$842,500.00View SEC Filing  
9/16/2014A Blaine BowmanDirectorSell5,000$169.60$848,000.00View SEC Filing  
9/15/2014Daniel BradburyDirectorSell2,100$168.57$353,997.00View SEC Filing  
9/15/2014Jay T FlatleyCEOSell25,000$176.06$4,401,500.00View SEC Filing  
9/15/2014Marc StapleyCFOSell1,422$169.05$240,389.10View SEC Filing  
9/15/2014Nicholas NaclerioSVPSell2,000$169.53$339,060.00View SEC Filing  
9/9/2014A Blaine BowmanDirectorSell5,000$178.08$890,400.00View SEC Filing  
9/3/2014Christian O HenrySVPSell10,000$180.59$1,805,900.00View SEC Filing  
9/3/2014Daniel BradburyDirectorSell2,100$179.77$377,517.00View SEC Filing  
9/2/2014A Blaine BowmanDirectorSell5,000$179.67$898,350.00View SEC Filing  
9/2/2014Michel BouchardVPSell686$180.07$123,528.02View SEC Filing  
9/2/2014Mostafa RonaghiSVPSell10,000$179.66$1,796,600.00View SEC Filing  
8/28/2014Jay T FlatleyCEOSell30,000$178.98$5,369,400.00View SEC Filing  
8/26/2014A Blaine BowmanDirectorSell5,000$179.22$896,100.00View SEC Filing  
8/22/2014Daniel BradburyDirectorSell2,100$172.24$361,704.00View SEC Filing  
8/19/2014A Blaine BowmanDirectorSell5,000$171.70$858,500.00View SEC Filing  
8/15/2014Nicholas NaclerioSVPSell2,000$167.23$334,460.00View SEC Filing  
8/15/2014Roy A WhitfieldDirectorSell4,000$169.28$677,120.00View SEC Filing  
8/13/2014Christian O HenrySVPSell20,000$164.66$3,293,200.00View SEC Filing  
8/5/2014A Blaine BowmanDirectorSell5,000$159.91$799,550.00View SEC Filing  
8/4/2014Daniel BradburyDirectorSell2,100$159.77$335,517.00View SEC Filing  
8/1/2014Mostafa RonaghiSVPSell10,000$159.73$1,597,300.00View SEC Filing  
7/29/2014A Blaine BowmanDirectorSell5,000$166.89$834,450.00View SEC Filing  
7/29/2014Christian O HenrySVPSell10,000$167.40$1,674,000.00View SEC Filing  
7/24/2014Jay T FlatleyCEOSell30,000$175.43$5,262,900.00View SEC Filing  
7/23/2014Daniel BradburyDirectorSell2,100$177.87$373,527.00View SEC Filing  
7/15/2014Nicholas NaclerioSVPSell2,000$174.26$348,520.00View SEC Filing  
7/14/2014Marc StapleyCFOSell1,422$177.59$252,532.98View SEC Filing  
7/10/2014Jay T FlatleyCEOSell30,000$172.56$5,176,800.00View SEC Filing  
7/8/2014Daniel BradburyDirectorSell2,100$172.89$363,069.00View SEC Filing  
7/1/2014Mostafa RonaghiSVPSell10,000$179.47$1,794,700.00View SEC Filing  
6/30/2014Gerald MoellerDirectorSell5,000$178.97$894,850.00View SEC Filing  
6/27/2014Daniel BradburyDirectorSell2,100$171.65$360,465.00View SEC Filing  
6/26/2014Jay T FlatleyCEOSell30,000$170.11$5,103,300.00View SEC Filing  
6/24/2014Christian O HenrySVPSell10,000$172.60$1,726,000.00View SEC Filing  
6/16/2014Christian O HenrySVPSell20,000$169.73$3,394,600.00View SEC Filing  
6/16/2014Marc StapleyCFOSell1,422$169.25$240,673.50View SEC Filing  
6/12/2014Daniel BradburyDirectorSell2,100$171.17$359,457.00View SEC Filing  
6/12/2014Jay T FlatleyCEOSell30,000$172.25$5,167,500.00View SEC Filing  
6/2/2014Karin EasthamDirectorSell6,000$157.56$945,360.00View SEC Filing  
6/2/2014Michel BouchardCAOSell1,491$155.51$231,865.41View SEC Filing  
6/2/2014Mostafa RonaghiSVPSell10,000$156.93$1,569,300.00View SEC Filing  
5/22/2014Jay FlatleyCEOSell30,000$154.95$4,648,500.00View SEC Filing  
5/15/2014Nicholas NaclerioSVPSell2,000$141.72$283,440.00View SEC Filing  
5/15/2014Roy WhitfieldDirectorSell4,000$143.71$574,840.00View SEC Filing  
5/14/2014Daniel BradburyDirectorSell2,100$146.46$307,566.00View SEC Filing  
5/14/2014Marc StapleyCFOSell1,422$146.94$208,948.68View SEC Filing  
5/8/2014Jay FlatleyCEOSell30,000$143.59$4,307,700.00View SEC Filing  
5/2/2014Daniel BradburyDirectorSell2,100$139.66$293,286.00View SEC Filing  
5/1/2014Mostafa RonaghiSVPSell10,000$135.91$1,359,100.00View SEC Filing  
4/24/2014Jay FlatleyCEOSell30,000$150.80$4,524,000.00View SEC Filing  
4/15/2014Daniel BradburyDirectorSell2,100$131.29$275,709.00View SEC Filing  
4/15/2014Nicholas NaclerioSVPSell2,000$133.56$267,120.00View SEC Filing  
4/14/2014Marc StapleyCFOSell1,422$134.80$191,685.60View SEC Filing  
4/10/2014Jay FlatleyCEOSell30,000$139.90$4,197,000.00View SEC Filing  
4/4/2014Daniel BradburyDirectorSell2,100$138.44$290,724.00View SEC Filing  
4/1/2014Mostafa RonaghiSVPSell10,000$152.41$1,524,100.00View SEC Filing  
3/27/2014Jay FlatleyCEOSell30,000$140.11$4,203,300.00View SEC Filing  
3/19/2014Daniel BradburyDirectorSell2,100$161.14$338,394.00View SEC Filing  
3/17/2014Gerald MoellerDirectorSell10,000$161.92$1,619,200.00View SEC Filing  
3/17/2014Nicholas NaclerioSVPSell2,000$163.65$327,300.00View SEC Filing  
3/14/2014Marc StapleyCFOSell1,422$163.35$232,283.70View SEC Filing  
3/13/2014Jay FlatleyCEOSell30,000$165.96$4,978,800.00View SEC Filing  
3/11/2014Christian HenrySVPSell3,000$167.16$501,480.00View SEC Filing  
3/11/2014Michel BouchardCAOSell2,168$167.21$362,511.28View SEC Filing  
3/3/2014Michel BouchardCAOSell2,994$176.81$529,369.14View SEC Filing  
2/25/2014Michel BouchardCAOSell24,505$176.13$4,316,065.65View SEC Filing  
2/24/2014Roy WhitfieldDirectorSell2,000$175.26$350,520.00View SEC Filing  
2/18/2014Nicholas NaclerioSVPSell2,000$169.77$339,540.00View SEC Filing  
2/13/2014Jay FlatleyCEOSell30,000$160.43$4,812,900.00View SEC Filing  
2/7/2014Jay FlatleyCEOSell5,000$152.23$761,150.00View SEC Filing  
1/31/2014Marc StapleyCFOSell20,038$151.32$3,032,150.16View SEC Filing  
1/23/2014Jay FlatleyCEOSell30,000$142.30$4,269,000.00View SEC Filing  
1/9/2014Jay FlatleyCEOSell30,000$114.77$3,443,100.00View SEC Filing  
12/26/2013Jay FlatleyCEOSell30,000$107.88$3,236,400.00View SEC Filing  
12/17/2013Gregory HeathSVPSell1,875$102.68$192,525.00View SEC Filing  
10/30/2013Christian O HenrySVPSell6,000$93.29$559,740.00View SEC Filing  
10/30/2013David R WaltDirectorSell5,000$93.02$465,100.00View SEC Filing  
10/28/2013William H RastetterDirectorSell20,000$92.37$1,847,400.00View SEC Filing  
10/24/2013Jay T FlatleyCEOSell30,000$92.32$2,769,600.00View SEC Filing  
10/22/2013Nicholas NaclerioSVPSell20,000$90.00$1,800,000.00View SEC Filing  
10/17/2013Gregory HeathSVPSell1,875$82.09$153,918.75View SEC Filing  
10/16/2013David R WaltDirectorSell5,000$82.59$412,950.00View SEC Filing  
10/15/2013Nicholas NaclerioSVPSell4,000$81.32$325,280.00View SEC Filing  
10/10/2013Christian HenrySVPSell6,000$77.73$466,380.00View SEC Filing  
10/10/2013Jay FlatleyCEOSell20,000$77.75$1,555,000.00View SEC Filing  
10/2/2013David R WaltDirectorSell5,000$80.58$402,900.00View SEC Filing  
9/18/2013David WaltDirectorSell5,000$83.11$415,550.00View SEC Filing  
9/17/2013Gregory HeathSVPSell1,875$85.20$159,750.00View SEC Filing  
9/16/2013Jay FlatleyCEOSell30,000$83.27$2,498,100.00View SEC Filing  
9/16/2013Nicholas NaclerioSVPSell4,000$85.00$340,000.00View SEC Filing  
9/10/2013Gregory HeathSVPSell1,875$82.00$153,750.00View SEC Filing  
9/9/2013Paul L BianchiSVPSell1,627$79.03$128,581.81View SEC Filing  
9/5/2013Christian O HenrySVPSell9,000$78.17$703,530.00View SEC Filing  
9/4/2013David R WaltDirectorSell5,000$77.18$385,900.00View SEC Filing  
9/3/2013Nicholas NaclerioSVPSell59,000$76.91$4,537,690.00View SEC Filing  
9/3/2013Roy A WhitfieldDirectorSell2,000$78.49$156,980.00View SEC Filing  
8/30/2013Mark LewisSVPSell5,000$78.12$390,600.00View SEC Filing  
8/22/2013Jay FlatleyCEOSell20,000$78.65$1,573,000.00View SEC Filing  
8/21/2013David WaltDirectorSell5,000$78.34$391,700.00View SEC Filing  
8/15/2013Nicholas NaclerioSVPSell2,000$78.43$156,860.00View SEC Filing  
8/8/2013Jay FlatleyCEOSell20,000$78.07$1,561,400.00View SEC Filing  
8/7/2013David WaltDirectorSell5,000$78.29$391,450.00View SEC Filing  
8/2/2013Michel BouchardVPSell11,465$80.64$924,537.60View SEC Filing  
7/25/2013Christian O HenrySVPSell11,462$80.89$927,161.18View SEC Filing  
7/25/2013Jay T FlatleyCEOSell20,000$81.01$1,620,200.00View SEC Filing  
7/24/2013David R WaltDirectorSell4,600$81.44$374,624.00View SEC Filing  
7/24/2013Gregory HeathSVPSell209,533$82.00$17,181,706.00View SEC Filing  
7/24/2013Michel BouchardVPSell9,789$79.28$776,071.92View SEC Filing  
7/15/2013Nicholas NaclerioSVPSell2,000$74.50$149,000.00View SEC Filing  
7/11/2013Jay T FlatleyCEOSell20,000$74.90$1,498,000.00View SEC Filing  
7/11/2013Mostafa RonaghiSVPSell24,000$74.95$1,798,800.00View SEC Filing  
7/10/2013David R WaltDirectorSell5,000$74.26$371,300.00View SEC Filing  
7/10/2013Michel BouchardVPSell3,618$74.30$268,817.40View SEC Filing  
7/9/2013Christian O HenrySVPSell9,000$74.01$666,090.00View SEC Filing  
6/27/2013Jay T FlatleyCEOSell20,000$74.96$1,499,200.00View SEC Filing  
6/26/2013David R WaltDirectorSell5,000$75.36$376,800.00View SEC Filing  
6/26/2013Michel BouchardVPSell4,272$75.06$320,656.32View SEC Filing  
6/25/2013Tristan OrpinSVPSell35,000$71.98$2,519,300.00View SEC Filing  
6/17/2013Nicholas NaclerioSVPSell2,000$68.56$137,120.00View SEC Filing  
6/14/2013Christian O HenrySVPSell25,959$68.10$1,767,807.90View SEC Filing  
6/13/2013Jay T FlatleyCEOSell20,000$66.49$1,329,800.00View SEC Filing  
6/13/2013Tristan OrpinSVPSell47,667$66.55$3,172,238.85View SEC Filing  
6/12/2013David R WaltDirectorSell5,000$67.67$338,350.00View SEC Filing  
6/12/2013Michel BouchardVPSell5,170$68.64$354,868.80View SEC Filing  
6/11/2013Mostafa RonaghiSVPSell24,000$69.01$1,656,240.00View SEC Filing  
6/3/2013Karin EasthamDirectorSell10,000$70.34$703,400.00View SEC Filing  
5/31/2013Mark L LewisSVPSell13,000$71.72$932,360.00View SEC Filing  
5/30/2013Matthew L PosardSVPSell2,836$70.80$200,788.80View SEC Filing  
5/29/2013David R WaltDirectorSell5,000$70.92$354,600.00View SEC Filing  
5/29/2013Michel BouchardVPSell6,276$71.02$445,721.52View SEC Filing  
5/21/2013Jay T FlatleyCEOSell24,000$69.39$1,665,360.00View SEC Filing  
5/20/2013Marc StapleyCFOSell2,843$73.38$208,619.34View SEC Filing  
5/15/2013David R WaltDirectorSell5,000$70.73$353,650.00View SEC Filing  
5/15/2013Michel BouchardVPSell14,241$70.71$1,006,981.11View SEC Filing  
5/15/2013Nicholas NaclerioSVPSell2,000$70.72$141,440.00View SEC Filing  
5/13/2013Mostafa RonaghiSVPSell24,000$68.83$1,651,920.00View SEC Filing  
5/10/2013Tristan OrpinSVPSell25,000$69.60$1,740,000.00View SEC Filing  
5/9/2013Jay T FlatleyCEOSell20,000$66.63$1,332,600.00View SEC Filing  
5/7/2013Tristan OrpinSVPSell5,000$65.68$328,400.00View SEC Filing  
4/8/2013Christian CabouSVPSell16,500$55.00$907,500.00View SEC Filing  
4/8/2013Marc StapleyCFOSell9,175$55.00$504,625.00View SEC Filing  
4/8/2013William H RastetterDirectorSell20,000$54.95$1,099,000.00View SEC Filing  
3/11/2013Marc StapleyCFOSell4,468$53.71$239,976.28View SEC Filing  
11/8/2012Jay T FlatleyCEOSell5,000$47.99$239,950.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Illumina (NASDAQ:ILMN)
Latest Headlines for Illumina (NASDAQ:ILMN)
Source:
DateHeadline
finance.yahoo.com logoHelix: An 'app' store for your DNA
finance.yahoo.com - July 24 at 11:34 PM
finance.yahoo.com logoETFs with exposure to Illumina, Inc. : July 24, 2017
finance.yahoo.com - July 24 at 11:34 PM
finance.yahoo.com logoHelix Bets An 'App Store' Can Make Consumers Care About Their DNA
finance.yahoo.com - July 24 at 8:11 AM
americanbankingnews.com logoInsider Selling: Illumina, Inc. (ILMN) Director Sells 15,000 Shares of Stock
www.americanbankingnews.com - July 20 at 10:24 PM
americanbankingnews.com logoIllumina, Inc. (NASDAQ:ILMN) EVP Marc Stapley Sells 2,000 Shares
www.americanbankingnews.com - July 17 at 10:14 PM
investorplace.com logo4 Tech Stocks Showing More Bite Than the FANGs - Investorplace.com
investorplace.com - July 17 at 3:48 PM
finance.yahoo.com logoETFs with exposure to Illumina, Inc. : July 14, 2017
finance.yahoo.com - July 15 at 1:56 AM
finance.yahoo.com logo6 Growth Stocks That Will Outlast a Bear Market
finance.yahoo.com - July 13 at 3:07 AM
americanbankingnews.com logoIllumina, Inc. (ILMN) Expected to Post Quarterly Sales of $642.50 Million
www.americanbankingnews.com - July 12 at 9:34 AM
finance.yahoo.com logoIllumina to Announce Second Quarter 2017 Financial Results on Tuesday, August 1, 2017
finance.yahoo.com - July 11 at 11:48 PM
americanbankingnews.com logoOmead Ostadan Sells 1,672 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - July 11 at 10:52 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - July 11 at 5:30 PM
americanbankingnews.com logoIllumina, Inc. (NASDAQ:ILMN) Rating Reiterated by Morgan Stanley
www.americanbankingnews.com - July 10 at 10:20 PM
americanbankingnews.com logoZacks: Brokerages Expect Illumina, Inc. (ILMN) to Post $0.68 EPS
www.americanbankingnews.com - July 10 at 8:08 PM
nasdaq.com logoMonday Sector Laggards: Services, Healthcare
www.nasdaq.com - July 10 at 7:47 PM
americanbankingnews.com logoJay T. Flatley Sells 15,000 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - July 7 at 7:56 PM
finance.yahoo.com logo3 Charts That Every Illumina, Inc. Investor Needs to See
finance.yahoo.com - July 6 at 5:44 AM
americanbankingnews.com logoCharles Dadswell Sells 145 Shares of Illumina, Inc. (NASDAQ:ILMN) Stock
www.americanbankingnews.com - July 5 at 10:44 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Cut to Sell at BidaskClub
www.americanbankingnews.com - July 5 at 8:38 PM
americanbankingnews.com logoIllumina, Inc. (NASDAQ:ILMN) Upgraded to Strong-Buy at Vetr Inc.
www.americanbankingnews.com - July 3 at 5:10 PM
fool.com logoBetter Buy: Illumina, Inc. vs. Roche Holding Ltd. (ADR) -- The Motley ... - Motley Fool
www.fool.com - July 2 at 12:22 AM
streetinsider.com logoIllumina (ILMN) Granted FDA Approval for Next-Generation Sequencing Cancer Companion Diagnostic Test Kit - StreetInsider.com
www.streetinsider.com - June 30 at 7:55 PM
seekingalpha.com logoIllumina updates on cancer companion diagnostic test kit - Seeking Alpha
seekingalpha.com - June 30 at 7:55 PM
finance.yahoo.com logoETFs with exposure to Illumina, Inc. : June 30, 2017
finance.yahoo.com - June 30 at 7:55 PM
streetinsider.com logoIllumina (ILMN) Granted FDA Approval for Next-Generation Sequencing Cancer Companion Diagnostic Test Kit
www.streetinsider.com - June 30 at 12:08 AM
finance.yahoo.com logoIllumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit
finance.yahoo.com - June 30 at 12:08 AM
seekingalpha.com logoIf You Like Illumina, You'll Love Genomic Health - Seeking Alpha
seekingalpha.com - June 27 at 6:04 PM
americanbankingnews.com logoIllumina, Inc. to Post FY2018 Earnings of $4.35 Per Share, Cantor Fitzgerald Forecasts (ILMN)
www.americanbankingnews.com - June 26 at 8:54 AM
finance.yahoo.com logoGenomics England Adopts Illumina’s BaseSpace Variant Interpreter for Cancer
finance.yahoo.com - June 26 at 4:34 AM
americanbankingnews.com logoIllumina, Inc. (ILMN) Upgraded by BidaskClub to "Hold"
www.americanbankingnews.com - June 24 at 6:10 PM
nasdaq.com logoIWP, ISRG, EA, ILMN: Large Outflows Detected at ETF
www.nasdaq.com - June 23 at 11:17 PM
finance.yahoo.com logoIllumina, Inc. breached its 50 day moving average in a Bullish Manner : ILMN-US : June 23, 2017
finance.yahoo.com - June 23 at 11:17 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Insider Sells $45,510.00 in Stock
www.americanbankingnews.com - June 23 at 10:34 PM
finance.yahoo.com logoIllumina Shines as Another Biotech Winner
finance.yahoo.com - June 22 at 10:31 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Director Jay T. Flatley Sells 20,000 Shares
www.americanbankingnews.com - June 22 at 7:26 PM
americanbankingnews.com logoVetr Inc. Downgrades Illumina, Inc. (ILMN) to Buy
www.americanbankingnews.com - June 22 at 12:34 AM
americanbankingnews.com logoBoston Scientific Corporation (BSX) vs. Illumina (ILMN) Financial Survey
www.americanbankingnews.com - June 21 at 7:52 AM
nasdaq.com logoAgree To Buy Illumina At $125, Earn 5.5% Using Options
www.nasdaq.com - June 20 at 6:46 PM
finance.yahoo.com logoETFs with exposure to Illumina, Inc. : June 19, 2017
finance.yahoo.com - June 19 at 4:51 PM
bizjournals.com logoDaily Technical Summary Reports on Biotech Stocks -- Illumina, Navidea Biopharma, Grifols, and Intercept Pharma
www.bizjournals.com - June 16 at 6:45 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 16 at 2:40 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Expected to Announce Quarterly Sales of $642.50 Million
www.americanbankingnews.com - June 16 at 1:52 PM
americanbankingnews.com logoInsider Selling: Illumina, Inc. (ILMN) EVP Sells 2,000 Shares of Stock
www.americanbankingnews.com - June 14 at 10:50 PM
americanbankingnews.com logo$0.69 EPS Expected for Illumina, Inc. (ILMN) This Quarter
www.americanbankingnews.com - June 14 at 8:19 PM
finance.yahoo.com logoCoalition for Access to Prenatal Screening Announces Clinical Advisory Board
finance.yahoo.com - June 13 at 10:56 AM
americanbankingnews.com logoIllumina, Inc. (ILMN) Upgraded at Vetr Inc.
www.americanbankingnews.com - June 12 at 9:08 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Insider Michel Bouchard Sells 246 Shares
www.americanbankingnews.com - June 9 at 4:15 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Director Sells $3,604,800.00 in Stock
www.americanbankingnews.com - June 8 at 7:12 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Files Amended Complaint Against Illumina, Inc. and Senior Officers
finance.yahoo.com - June 8 at 6:50 PM
finance.yahoo.com logoETFs with exposure to Illumina, Inc. : June 8, 2017
finance.yahoo.com - June 8 at 6:50 PM

Social

Chart

Illumina (ILMN) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff